Diagnosis and treatment of chronic rhinosinusitis in adults. Expert consensus: Asociación Colombiana de Otorrinolaringología -2021.
Article Sidebar
Main Article Content
Abstract
Introduction: Chronic Rhinosinusitis is defined as chronic inflammation of thenose and paranasal sinuses for more than 12 weeks. The prevalence varies between 5% - 30% depending on the geographical area according to a disease burden study (2012-2014), the prevalence of chronic respiratory diseases (rhinitis and chronic
sinusitis) varied between 10% - 25%. Objective: To establish a set of considerations based on expert consensus, for the diagnosis and treatment of chronic rhinosinusitis in adult patients, in the Colombian context. Methods: A formal consensus (Delphi and nominal) was carried out. A group of experts was formed, the scope and questions were defined. Two anonymous grading rounds were conducted, and a discussion for questions without consensus. In the Questions with options from one to
nine were considered consensus with a median of one to three or seven to nine. In the Likert-type questions, a percentage equal to or greater than 80% in agreements or disagreements was considered consensus. Results: 18 questions were defined
and scored, with the participation of 17 otorhinolaryngologists, from eight Colombian
cities, all members of the Colombian Association of Otorhinolaryngology and with an average experience of 19.2 years (Standard desviation [SD]: 10.2). 18 recommendations were obtained for the diagnosis and treatment of this pathology.
Conclusions: The recommendations issued by the experts allow to guide and standardize
the diagnosis and treatment of chronic rhinosinusitis in adults, in the context of health services in Colombia.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.
Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.
eISSN: 2539-0856
ISSN: 0120-8411
References
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and
Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi:10.4193/Rhin20.600
Alvo A, Barahona L, Aranibar H, Gianini R. Rinosinusitis crónica: una revisión de su etiopatogenia. Rev Otorrinolaringol
Cir Cabeza Cuello. 2018;78(4):451-62.
Morbi-mortalidad de las enfermedades respiratorias crónicas, Colombia 2005-2013 [Internet]. Minsalud; 2015 [Acceso
. Disponible en: https://www.minsalud.gov.co/sites/rid/ Lists/BibliotecaDigital/RIDE/VS/PP/ENT/morbimortalidadenfer-resp-cronica-2017.pdf
Silva R, Parra DP, García LE. Factores pronósticos para cirugía endoscópica funcional en rinosinusitis crónica: una revisión de la literatura actual. Revista Med. 2011;19(2):232-40.
Muñoz-Carlin ML, Nevárez-Sida A, García-Contreras F, Mendieta-Sevilla SR, Constantino-Casas P. Costo-efectividad
del tratamiento de rinosinusitis aguda y crónica en el IMSS. Rev Invest Clin. 2007;59(3):197-205.
Hamilos DL, EH H. Chronic rhinosinusitis: Management [Internet]. UpToDay; 2021 [Acceso 2021]. Disponible en:
https://www.uptodate.com/contents/chronic-rhinosinusitismanagement? search=Chronic%20rhinosinusitis:%20
Management%20&source=search_result&selectedTitle=2~14 5&usage_type=default&display_rank=2
Marrugo G, Rodríguez P. Guía para el diagnóstico de rinosinusitis del adulto [Internet]. ACORL; 2016 [Acceso:
. Disponible en: https://www.acorl.org.co/resources/imagenes/visitante/medico/apoyo-al-ejercicio-profesional/ guias-acorl/GUIAS_ACORL_Sinusitis_en_el_adulto.pdf
Vargas Duque R, Milanés Pérez R, Carmona Meza Z. Factores ambientales asociados a Rinosinusitis crónica. Hospital
Universitario del Caribe, Cartagena (Colombia). Salud Uninorte. 2018;34(3):727-36.
Rot P, Rapiejko P, Jurkiewicz D. Intranasal steroid therapy- EPOS 2020. Otolaryngol Pol. 2020;74(3):41-49. doi:
5604/01.3001.0014.2449
Borish L, Baroody FM, Kim MS, Lieberman JA, Peters A, Stevens WW, et al. Yardstick for the medical management
of chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2022;128(2):118-128. doi: 10.1016/j.anai.2021.10.014
Chong L-Y, Piromchai P, Sharp S, Snidvongs K, Webster KE, Philpott C, et al. Biologics for chronic rhinosinusitis. Cochrane; 2021 [Acceso: 2021]. Disponible en: https://www.cochrane.org/es/CD013513/ENT_productos-biologicos-para-personascon-rinosinusitis-cronica
Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, et al. IDSA clinical practice guideline for acute
bacterial rhinosinusitis in children and adults. Clin Infect Dis.2012;54(8):e72-e112. doi: 10.1093/cid/cir1043
Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus
guidelines. Mayo Clin Proc. 2011;86(5):427-43. doi: 10.4065/mcp.2010.0392
De Vilhena D, Duarte D, Lopes G. Calidad de vida en la rinosinusitis crónica con poliposis nasal. Revista ORL.
;7(1):17-22. doi: 10.14201/orl.13527
Malaty J. Medical Management of Chronic Rhinosinusitis in Adults. Sinusitis. 2016;1(1):76-87. doi: 10.3390/
sinusitis1010076
Head K, Sharp S, Chong LY, Hopkins C, Philpott C. Topical and systemic antifungal therapy for chronic rhinosinusitis.
Cochrane Database Syst Rev. 2018;9(9):CD012453. doi:10.1002/14651858.CD012453.pub2
Valdés PC, Muñoz MT, Barría ET, Bogado BM, Ruz MP, Cardemil MF, et al. Validación de encuesta de calidad de
vida SNOT-22 en población chilena. Rev Otorrinolaringol Cir Cabeza Cuello. 2020;80(4):425-33. doi: 10.4067/S0718-
Chi-Cauich IK, Castañeda-De León MR. Prueba SNOT-22 para valorar mejoría clínica en cirugía rinosinusal. An Orl Mex.
;66(2):104-9. doi: 10.24245/aorl.v66i2.4437
Arndal E, Sorensen AL, Lapperre TS, Said N, Trampedach C, Aanæs K, et al. Chronic rhinosinusitis in COPD: A prevalent
but unrecognized comorbidity impacting health related quality of life. Respir Med. 2020;171:106092. doi: 10.1016/j.
rmed.2020.106092
Bayar Muluk N, Cingi C, Scadding GK, Scadding G. Chronic Rhinosinusitis-Could Phenotyping or Endotyping
Aid Therapy? Am J Rhinol Allergy. 2019;33(1):83-93. doi:10.1177/1945892418807590
Soler ZM, Schlosser RJ, Bodner TE, Alt JA, Ramakrishnan VR, Mattos JL, et al. Endotyping chronic rhinosinusitis based
on olfactory cleft mucus biomarkers. J Allergy Clin Immunol. 2021;147(5):1732-1741.e1. doi: 10.1016/j.jaci.2021.01.021
Carroll Patiño MP, Silva R. Eosinofilia periférica como factor de severidad tomográfica en rinosinusitis crónica. Acta
Otorrinolaringol Cir Cabeza Cuello. 2020;48(2):142-9. doi:10.37076/acorl.v48i2.533
Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with
sinusitis with complications. Laryngoscope. 2002;112(2):224-9. doi: 10.1097/00005537-200202000-00005
Wu AW, Borrelli M, Raskin J, Hopp ML, Mirocha J, Tang DM. Correlation of chronic rhinosinusitis-related symptoms with
computed tomography subsite. Int Forum Allergy Rhinol. 2021.doi: 10.1002/alr.22920
Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117(3 Pt 2):S35-40. doi: 10.1016/s0194-5998(97)70005-6
Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of
rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1-84. doi: 10.1016/j.jaci.2008.06.003
Krauss K, Nazar R, Naser A, Cabrera N. Patología unilateral de senos paranasales con compromiso predominante de un
seno. Descripción de serie de casos. Rev Otorrinolaringol Cir Cabeza Cuello. 2016;76(2):193-200. doi: 10.4067/S0718-
Xu Z, Luo X, Xu L, Deng J, Gao W, Jiang L, et al. Effect of short-course glucocorticoid application on patients with
chronic rhinosinusitis with nasal polyps. World Allergy Organ J. 2020;13(6):100131. doi: 10.1016/j.waojou.2020.100131
Head K, Chong L, Hopkins C, Philpott C, Schilder AGM, Burton MJ. Corticosteroides orales a corto plazo además de otros tratamientos para la rinosinusitis crónica [Internet]. Cochrane; 2016 [Acceso 2021]. Disponible en: https://www.cochrane.org/es/CD011992/ENT_corticosteroides-orales-corto-plazoademas-de-otros-tratamientos-para-la-rinosinusitis-cronica
Andrews PJ, Poirrier AL, Lund VJ, Choi D. Outcomes in endoscopic sinus surgery: olfaction, nose scale and quality
of life in a prospective cohort study. Clin Otolaryngol. 2016;41(6):798-803. doi: 10.1111/coa.12665
Patel GB, Peters AT. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Ear Nose Throat J.
;100(1):44-47. doi: 10.1177/0145561320964653
Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, etal. Canadian Rhinology Working Group consensus statement:biologic therapies for chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2021;50(1):15. doi: 10.1186/s40463-021-00493-2
Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E, Krysko O. Biologics for chronic rhinosinusitis with nasal
polyps. J Allergy Clin Immunol. 2020;145(3):725-739. doi:10.1016/j.jaci.2020.01.020
Ghogomu N, Kern R. Chronic rhinosinusitis: the rationale for current treatments. Expert Rev Clin Immunol. 2017;13(3):259-270. doi: 10.1080/1744666X.2016.1220833